申请人:Actelion Pharmaceuticals Ltd.
公开号:US08288411B2
公开(公告)日:2012-10-16
The invention relates to compounds of formula (I) wherein Y, A, N and R1 are as described in the description, to salts, especially pharmaceutically acceptable salts, of such compounds and to the use of such compounds as medicaments, especially as orexin receptor antagonists.
本发明涉及式(I)的化合物,其中Y、A、N和R1如描述中所述,以及该化合物的盐,特别是药学上可接受的盐,以及将该化合物用作药物,特别是作为促进睡眠的药物。